Privcap / Bios / Mike Liang

Mike Liang

Partner, Baird Capital

Mike Liang joined Baird Capital in 2006 and concentrates on healthcare investments. Prior to joining Baird Capital, Mike Liang was a venture investor with Advent Venture Partners and before that, served in an operating role as a Director of R&D at Cortek, a spinal orthopedics company. Mike Liang is currently a member of the board of directors of Amphora Medical, GenomeDx Biosciences, Insightra Medical, Palyon Medical, PathCentral, Veniti, and Zurex Pharma. He was previously a board member of Interlace Medical before its acquisition in 2011 and a board observer of TomoTherapy before its public offering.

Videos

Reports

  • Dealmaker

    PE Value – Creation Stories

    An executive summary of the Privcap series exploring how GPs create value. In this briefing—produced in partnership with EY—you’ll find 10 case studies detailing how private equity improves portfolio companies.

    May 11, 2015
    More
  • Emerging Markets

    Special Report: Healthcare

    In this subscriber-only special report, Privcap talks to private equity leaders who invest in the healthcare sector about what investment opportunities exist, including in emerging markets, and how private capital and innovation are combining to build value in a changing market.

    January 12, 2015
    More
  • Dealmaker

    Value Creation Stories

    An executive summary of the Privcap series exploring how GPs create portfolio company value.

    May 19, 2014
    More